Publication | Closed Access

Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients

OncologyMedicineGastroenterologyColorectal CancerProton Pump InhibitorsConcomitant AdministrationPharmacotherapyRecurrence RiskCancer TreatmentPharmacologyRadiation Oncology